{
  "itemId": "MISSION-500-115-1771349552717",
  "itemType": "matrixMatch",
  "difficulty": 5,
  "questionText": "The nurse is reviewing the electronic health record for an 82-year-old client admitted for evaluation of nausea, anorexia, and visual disturbances. For each finding below, click to specify if it is consistent with the client's potential condition. Each finding may support more than one condition.",
  "exhibits": [
    {
      "id": "exhibit_1",
      "type": "EHR",
      "tabs": [
        {
          "title": "Nurses' Notes",
          "content": "<b>0800:</b> Client is an 82-year-old male with a history of HFrEF, atrial fibrillation, and Stage 3 CKD. Admitted from home with complaints of progressive nausea, anorexia, and 'seeing yellowish halos around lights' for the past 2 days. States he was started on furosemide two weeks ago. Lives in a rural area and missed his 1-week follow-up appointment due to lack of transportation. Client is alert, oriented to person and place only."
        },
        {
          "title": "Vital Signs",
          "content": "<h4>Vital Signs Trend</h4>\n| Time | T (Â°C) | HR (apical) | RR | BP | SpO2 |\n|---|---|---|---|---|---|\n| Yesterday 2000 | 36.8 | 62 | 18 | 118/72 | 96% RA |\n| Today 0400 | 36.7 | 54 | 16 | 114/70 | 97% RA |\n| Today 0800 | 36.6 | 48 | 18 | 110/68 | 96% RA |"
        },
        {
          "title": "Laboratory Results",
          "content": "<h4>Results from 0730</h4>\n<ul>\n<li><b>Sodium:</b> 138 mEq/L (136-145 mEq/L)</li>\n<li><b>Potassium:</b> 2.9 mEq/L (3.5-5.0 mEq/L) - <em>Critical Low</em></li>\n<li><b>BUN:</b> 45 mg/dL (10-20 mg/dL)</li>\n<li><b>Creatinine:</b> 1.8 mg/dL (0.6-1.2 mg/dL)</li>\n<li><b>Digoxin Level:</b> 2.4 ng/mL (Therapeutic: 0.8-2.0 ng/mL)</li>\n</ul>"
        },
        {
          "title": "Diagnostics",
          "content": "<b>ECG Interpretation (0745):</b> Sinus bradycardia with a heart rate of 48/min. First-degree atrioventricular (AV) block with a PR interval of 0.24 seconds. Downsloping ST-segment depression noted in leads V5-V6."
        },
        {
          "title": "MAR",
          "content": "<h4>Scheduled Medications - 0900</h4>\n<ul>\n<li>Lisinopril 10 mg PO DAILY</li>\n<li>Digoxin 0.125 mg PO DAILY</li>\n<li>Furosemide 40 mg PO DAILY</li>\n<li>Apixaban 5 mg PO BID</li>\n</ul>"
        }
      ]
    }
  ],
  "matrix": {
    "rows": [
      {
        "id": "row1",
        "label": "Serum Potassium 2.9 mEq/L"
      },
      {
        "id": "row2",
        "label": "Apical heart rate of 48/min"
      },
      {
        "id": "row3",
        "label": "Reports of 'yellowish halos'"
      },
      {
        "id": "row4",
        "label": "BUN 45 mg/dL & Creatinine 1.8 mg/dL"
      },
      {
        "id": "row5",
        "label": "First-degree AV block on ECG"
      }
    ],
    "columns": [
      {
        "id": "col1",
        "label": "Indicates Digoxin Toxicity"
      },
      {
        "id": "col2",
        "label": "Indicates Renal Impairment"
      },
      {
        "id": "col3",
        "label": "Indicates Need to Withhold Medication"
      }
    ]
  },
  "correctResponse": {
    "row1": [
      "col1",
      "col3"
    ],
    "row2": [
      "col1",
      "col3"
    ],
    "row3": [
      "col1",
      "col3"
    ],
    "row4": [
      "col1",
      "col2",
      "col3"
    ],
    "row5": [
      "col1",
      "col3"
    ]
  },
  "answerBreakdown": {
    "row1": {
      "col1": "Correct. Hypokalemia (Potassium < 3.5 mEq/L) significantly increases digoxin's effects on the myocardium, raising the risk of toxicity even at therapeutic levels. Low potassium enhances digoxin binding to Na+/K+-ATPase, inhibiting its function and disrupting cellular ion gradients, leading to arrhythmias and other toxic effects. The client's K+ of 2.9 mEq/L is a major contributor to digoxin toxicity.",
      "col2": "Incorrect. Hypokalemia is an electrolyte imbalance, not a direct indicator of renal impairment. Renal impairment is indicated by elevated BUN and creatinine, which reflect the kidney's reduced ability to filter waste products.",
      "col3": "Correct. Significant hypokalemia necessitates withholding digoxin. Administering digoxin with low potassium can precipitate life-threatening cardiotoxicity due to increased digoxin binding and enhanced inhibition of Na+/K+-ATPase in cardiac cells."
    },
    "row2": {
      "col1": "Correct. Digoxin has a negative chronotropic effect, slowing the heart rate by increasing vagal tone and decreasing sympathetic activity at the sinoatrial (SA) node. Severe bradycardia (HR < 60/min), especially a rate of 48/min, is a classic sign of digoxin toxicity as the drug's effect on the SA node becomes excessive, potentially leading to sinus arrest or AV block.",
      "col2": "Incorrect. Bradycardia is a cardiovascular sign, not a direct indicator of renal function. While renal impairment can cause digoxin toxicity, which leads to bradycardia, the heart rate itself does not indicate the state of the kidneys.",
      "col3": "Correct. An apical heart rate below 60/min is a standard parameter for withholding digoxin. A rate of 48/min is a definitive 'STOP' sign, requiring the nurse to hold the medication and notify the provider immediately to prevent further slowing of the heart rate and potential cardiac arrest."
    },
    "row3": {
      "col1": "Correct. Visual disturbances, specifically xanthopsia (seeing yellow-green halos around objects), are a classic, though less common, neurotoxic symptom of digoxin toxicity. Digoxin affects the central nervous system, altering color perception and causing these characteristic visual changes due to interference with retinal function.",
      "col2": "Incorrect. Visual disturbances like xanthopsia are specific to digoxin toxicity and are not associated with renal impairment itself.",
      "col3": "Correct. The client's report of a hallmark symptom of toxicity is a clear indication that administering more of the drug would be dangerous. This finding mandates withholding the medication to prevent further neurotoxic effects and potential seizures."
    },
    "row4": {
      "col1": "Correct. Elevated BUN and Creatinine indicate renal impairment. Since digoxin is primarily cleared by the kidneys, poor renal function leads to drug accumulation and is a primary risk factor for developing toxicity. Reduced glomerular filtration rate (GFR) impairs digoxin excretion, increasing its serum concentration and the risk of adverse effects. The client's high levels confirm this risk factor is present and contributing to the toxic state.",
      "col2": "Correct. Elevated Blood Urea Nitrogen (BUN) and serum creatinine are the hallmark laboratory indicators of impaired kidney function (renal impairment). BUN reflects the amount of urea nitrogen in the blood, while creatinine is a waste product from muscle metabolism; both are normally filtered by the kidneys.",
      "col3": "Correct. The evidence of poor renal clearance means the client cannot effectively excrete the drug. Administering another dose would raise the blood level further into a dangerous range, so the medication must be withheld to prevent further accumulation and severe toxicity."
    },
    "row5": {
      "col1": "Correct. Digoxin slows conduction through the atrioventricular (AV) node by increasing vagal tone and prolonging the refractory period. In toxicity, this effect is exaggerated and can manifest as a first-degree AV block (PR interval > 0.20 seconds) or progress to more severe heart blocks. The client's PR interval of 0.24 seconds is a sign of toxic effect on the heart's conduction system, indicating impaired AV nodal conduction.",
      "col2": "Incorrect. AV block is a cardiac conduction abnormality and not a direct indicator of renal function, although it can be caused by the digoxin toxicity that resulted from renal impairment.",
      "col3": "Correct. Evidence of cardiotoxicity on the ECG, such as a new or worsening AV block, is an absolute contraindication to administering the next dose of digoxin. The nurse must withhold the dose to prevent progression to a life-threatening complete heart block and potential asystole."
    }
  },
  "cognitiveSkills": [
    "Assessment",
    "Analysis"
  ],
  "safeEffectiveCareEnvironment": [
    "Medication Administration",
    "Safety and Infection Control"
  ],
  "physiologicalIntegrity": [
    "Fluid and Electrolyte Balance",
    "Pharmacological and Parenteral Therapies",
    "Cardiovascular"
  ],
  "clientNeeds": [
    "Physiological Integrity"
  ],
  "content": [
    "Pharmacology",
    "Fluid and Electrolyte Imbalance",
    "Cardiovascular Disorders"
  ],
  "integratedProcesses": [
    "Nursing Process"
  ],
  "clinicalPearls": [
    "Hypokalemia significantly increases the risk of digoxin toxicity, even within the therapeutic range. Monitor potassium levels closely in patients on digoxin and diuretics.",
    "Visual disturbances, such as seeing yellow halos (xanthopsia), are a classic sign of digoxin toxicity. Inquire about visual changes in patients on digoxin.",
    "Renal impairment increases the risk of digoxin toxicity due to decreased drug clearance. Adjust digoxin dosage based on renal function.",
    "Bradycardia and AV block are cardiac manifestations of digoxin toxicity. Monitor heart rate and ECG in patients on digoxin.",
    "Always check apical pulse before administering digoxin; hold if <60 bpm and notify the provider. Document the reason for holding the medication."
  ],
  "sbar": {
    "situation": "0800: 82-year-old male admitted for nausea, anorexia, and visual disturbances. History of HFrEF, atrial fibrillation, and Stage 3 CKD.",
    "background": "Started on furosemide two weeks ago. Missed follow-up appointment due to transportation issues. Current medications include lisinopril, digoxin 0.125 mg PO daily, furosemide 40 mg PO daily, and apixaban 5 mg PO BID.",
    "assessment": "Potassium 2.9 mEq/L (critical low), BUN 45 mg/dL, Creatinine 1.8 mg/dL, Digoxin level 2.4 ng/mL (above therapeutic range). Apical HR 48/min, first-degree AV block on ECG (PR interval 0.24 seconds). Reports seeing yellowish halos.",
    "recommendation": "Hold digoxin immediately. Notify provider immediately regarding possible digoxin toxicity and hypokalemia. Anticipate orders for potassium replacement (oral or IV) and further evaluation of renal function. Monitor ECG continuously for worsening AV block or arrhythmias."
  },
  "sentinelStatus": "healed_v2026_v8"
}